|microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer|
FM Buffa, C Camps, L Winchester, CE Snell, HE Gee, H Sheldon, ...
Cancer research 71 (17), 5635-5645, 2011
|MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU|
E Favaro, A Ramachandran, R McCormick, H Gee, C Blancher, M Crosby, ...
PloS one 5 (4), e10345, 2010
|The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis|
HE Gee, FM Buffa, C Camps, A Ramachandran, R Leek, M Taylor, M Patil, ...
British journal of cancer 104 (7), 1168-1177, 2011
|hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer|
HE Gee, C Camps, FM Buffa, S Patiar, SC Winter, G Betts, J Homer, ...
Cancer 116 (9), 2148-2158, 2010
|MicroRNA-10b and breast cancer metastasis|
HE Gee, C Camps, FM Buffa, S Colella, H Sheldon, JM Gleadle, ...
Nature 455 (7216), E8-E9, 2008
|Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome|
RK Beckers, CI Selinger, R Vilain, J Madore, JS Wilmott, K Harvey, ...
Histopathology 69 (1), 25-34, 2016
|Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts|
K Kumar, S Wigfield, HE Gee, CM Devlin, D Singleton, JL Li, F Buffa, ...
Journal of molecular medicine 91 (6), 749-758, 2013
|HypoxamiRs and cancer: from biology to targeted therapy|
HE Gee, C Ivan, GA Calin, M Ivan
Antioxidants & redox signaling 21 (8), 1220-1238, 2014
|Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers|
X Zhang, H Gee, B Rose, CS Lee, J Clark, M Elliott, JR Gamble, ...
BMC cancer 16 (1), 1-11, 2016
|miR-139-5p modulates radiotherapy resistance in breast cancer by repressing multiple gene networks of DNA repair and ROS defense|
M Pajic, D Froio, S Daly, L Doculara, E Millar, PH Graham, A Drury, ...
Cancer research 78 (2), 501-515, 2018
|In vivo dosimetric impact of breast tissue expanders on post‐mastectomy radiotherapy|
HE Gee, F Bignell, D Odgers, S Gill, D Martin, J Toohey, S Carroll
Journal of Medical Imaging and Radiation Oncology 60 (1), 138-145, 2016
|Prognostic role of microRNAs in human non-small-cell lung cancer: a systematic review and meta-analysis|
SR Lamichhane, T Thachil, P De Ieso, H Gee, SA Moss, N Milic
Disease markers 2018, 2018
|MicroRNA-related DNA repair/cell-cycle genes independently associated with relapse after radiation therapy for early breast cancer|
HE Gee, FM Buffa, AL Harris, JM Toohey, SL Carroll, CL Cooper, J Beith, ...
International Journal of Radiation Oncology* Biology* Physics 93 (5), 1104-1114, 2015
|Molecular mechanisms of Radiation-Induced cancer cell death: a primer|
J Sia, R Szmyd, E Hau, HE Gee
Frontiers in cell and developmental biology 8, 41, 2020
|Contouring consensus guidelines in breast cancer radiotherapy: comparison and systematic review of patterns of failure|
HE Gee, L Moses, K Stuart, N Nahar, K Tiver, T Wang, R Ward, V Ahern
Journal of medical imaging and radiation oncology 63 (1), 102-115, 2019
|PDL1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome|
RK Beckers, C Selinger, R Vilain, J Madore, JS Wilmott, K Harvey, ...
Pathology 48, S146-S147, 2016
|High-risk cutaneous squamous cell carcinoma|
HE Gee, MJ Veness
Current Otorhinolaryngology Reports 6 (2), 120-128, 2018
|MicroRNA regulation of radiotherapy sensitivity and resistance in breast cancer|
HE Gee, DA Froio, LS Doculara, PH Graham, EKA Millar, SA O'Toole, ...
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 34, S12-S12, 2014
|Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas|
H Shen, K Cook, HE Gee, E Hau
Journal of Experimental & Clinical Cancer Research 39 (1), 1-14, 2020
|Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer|
A Dhawan, J Scott, P Sundaresan, M Veness, S Porceddu, E Hau, ...
Scientific reports 10 (1), 1-10, 2020